Merrion Pharmaceuticals Plc (3MP):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82696FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Merrion Pharmaceuticals Plc (Merrion) is a product development company. It offers prescription pharmaceutical products to meet unmet needs in healthcare. The company focuses on the development of drugs in oral forms such as tablets and capsules that have limited absorption, and are generally given by injection. It has developed GIPET, a patented drug delivery technology that increases bioavailability, by enhancing absorption levels in the gastrointestinal tract. Merrion’s product portfolio includes Orazol, Almero, Acyline and MER-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has agreements with several pharmaceutical companies; and through its license agreements with Novo Nordisk A/S develops and commercializes oral forms of Novo Nordisk’s Insulin and GLP-1, by utilizing the GIPET technology. Merrion is headquartered in Dublin, Ireland.

Merrion Pharmaceuticals Plc Key Recent Developments

Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of Director
Dec 23, 2013: Merrion Pharmaceuticals Announces Appointment of CEO and Chairman
Sep 30, 2013: Interim Results for the Six Months Ended 30 June 2013
Aug 20, 2013: Merrion Pharmaceuticals Announces Appointment of Non-Executive Director

This comprehensive SWOT profile of Merrion Pharmaceuticals Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Merrion Pharmaceuticals Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Merrion Pharmaceuticals Plc – Key Information
Merrion Pharmaceuticals Plc – Overview
Merrion Pharmaceuticals Plc – Key Employees
Merrion Pharmaceuticals Plc – Key Employee Biographies
Merrion Pharmaceuticals Plc – Key Operational Heads
Merrion Pharmaceuticals Plc – Major Products and Services
Merrion Pharmaceuticals Plc – History
Merrion Pharmaceuticals Plc – Company Statement
Merrion Pharmaceuticals Plc – Locations And Subsidiaries
Merrion Pharmaceuticals Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Merrion Pharmaceuticals Plc – Business Description
Merrion Pharmaceuticals Plc – Corporate Strategy
Merrion Pharmaceuticals Plc – SWOT Analysis
SWOT Analysis – Overview
Merrion Pharmaceuticals Plc – Strengths
Merrion Pharmaceuticals Plc – Weaknesses
Merrion Pharmaceuticals Plc – Opportunities
Merrion Pharmaceuticals Plc – Threats
Merrion Pharmaceuticals Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Merrion Pharmaceuticals Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Merrion Pharmaceuticals Plc, Key Information
Merrion Pharmaceuticals Plc, Key Ratios
Merrion Pharmaceuticals Plc, Share Data
Merrion Pharmaceuticals Plc, Major Products and Services
Merrion Pharmaceuticals Plc, History
Merrion Pharmaceuticals Plc, Key Employees
Merrion Pharmaceuticals Plc, Key Employee Biographies
Merrion Pharmaceuticals Plc, Key Operational Heads
Merrion Pharmaceuticals Plc, Other Locations
Merrion Pharmaceuticals Plc, Subsidiaries
Merrion Pharmaceuticals Plc, Key Manufacturing facilities
Merrion Pharmaceuticals Plc, Key Competitors
Merrion Pharmaceuticals Plc, SWOT Analysis
Merrion Pharmaceuticals Plc, Ratios based on current share price
Merrion Pharmaceuticals Plc, Annual Ratios
Merrion Pharmaceuticals Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Merrion Pharmaceuticals Plc, Performance Chart
Merrion Pharmaceuticals Plc, Ratio Charts

★海外企業調査レポート[Merrion Pharmaceuticals Plc (3MP):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LOT Polish Airlines S.A.(旅行・観光分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "LOT Polish Airlines S.A.: Travel and Tourism - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Antibiotice SA (ATB):企業概要、財務及び戦略的SWOT分析
    Summary Antibiotice SA (Antibiotice) is a drug manufacturing company. The company produces a wide range of medicines covering therapeutic areas such as anti-infective, cardiovascular, digestive, central nervous system, musculoskeletal, and dermatology. Antibiotice is the only manufacturer of active …
  • Alpha Bank Group (ALPHA)の企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Alpha Bank Group" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence …
  • PVI Holdings (PVI):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "PVI Holdings" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a st …
  • Verisk Analytics, Inc.:企業のM&A・提携・投資分析
    Verisk Analytics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Verisk Analytics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Parker Drilling Company (PKD):企業の財務及び戦略的SWOT分析
    Summary Parker Drilling Company (Parker) is an oil and gas company that provides drilling services. The company offers offshore and onshore contract drilling and drilling related services to its clients. Its offshore barge rigs operate mainly in the coastal waters of the US Gulf of Mexico. Parker al …
  • Techint Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Techint Group Mergers and Acqui …
  • Ali Baba:企業概要およびSWOT分析
    Summary Canadean's "Ali Baba: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key emplo …
  • Barco N.V. (BAR):企業のM&A・提携動向(医療機器分野)
    Summary Barco N.V. (Barco) is a manufacturer of networked visualization products. It designs, develops and sells visualization solutions for varied professional markets such as media and entertainment, corporate, healthcare, industrial, government, traffic and transportation and defense and aerospac …
  • Bark Group, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bark Group, Inc. Mergers and Ac …
  • OSI Systems, Inc. (OSIS):企業の財務・戦略的SWOT分析
    OSI Systems, Inc. (OSIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GeoPark Limited (GPRK):企業財務及び戦略的SWOT分析
    Summary GeoPark Limited (GeoPark) is an oil and gas company that explores, develops and produces oil and gas from its assets. The company holds asset platforms in Chile, Colombia, Argentina, Brazil and Peru. It also operates blocks in Fell, Tranquilo, Otway, Isla Norte, Flamenco and Campanario in Ma …
  • Aikchol Hospital Public Company Limited (AHC):企業概要、財務及び戦略的SWOT分析
    Summary Aikchol Hospital Public Company Limited (Aikchol Hospital) is a healthcare service provider. The hospital offers healthcare services, medical devices and other related services to patients. Its clinic centers and healthcare services include general medicine clinic, nephrology clinic, neurolo …
  • CEVA Group Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CEVA Group Plc Mergers and Acqu …
  • Reliance Power Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reliance Power Limited Mergers …
  • Maire Tecnimont S.p.A. (MT):企業のM&A・提携動向(石油・ガス分野)
    Summary Maire Tecnimont S.p.A. (Maire) is a provider of engineering and construction, technology and licensing, and energy business development and ventures services. The company focuses on the oil and gas, petrochemicals and fertilizer processing industries. It provides a broad range of services on …
  • Aptus Endosystems, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Aptus Endosystems, Inc. (Aptus) is a medical device company. The company develops and manufactures technology for endovascular aneurysm repair. It focuses on developing technologies to transform EVAR and provide physicians and patients with a definitive solution for AAA treatment. Aptus’s pr …
  • Turkish Airlines, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Turkish Airlines, Inc. Mergers …
  • Electrica SA (EL):企業の財務・戦略的SWOT分析
    Electrica SA (EL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Generex Biotechnology Corporation (GNBT):企業のM&A・提携動向(医療機器分野)
    Summary Generex Biotechnology Corporation (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large molecules in the areas of seasonal influenza virus, melanoma, ovarian cancer, HIV, HPV, alle …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆